PT  - JOURNAL ARTICLE
AU  - Alexander, Walter
ED  - Kitakaze, Masafumi
TI  - Effects of Carperitide and Nicorandil on Injury and Function in Patients with Acute MI: Results of the J-WIND Trial
DP  - 2006  01
TA  - MD Conference Express
PG  - 17--20
VI  - 6
IP  - 5
4099  - http://mdc.sagepub.com/content/6/5/17.short
4100  - http://mdc.sagepub.com/content/6/5/17.full
AB  - The results of the Japanese Working Groups of Acute Myocardial Infarction for the Reduction of Necrotic Damage by Atrial Natriuretic Peptide (ANP) or Nicorandil [J-WIND] trials conducted in Japan from 2001–2006. Carperitide, human recombinant ANP, is approved for the treatment of acute heart failure in Japan. Nicorandil, a nicotinamide nitrate that activates potassium channels in the heart, is used to treat chronic angina. These randomized, double-blind studies evaluated intervention with either carperitide or nicorandil on infarct size, left ventricular function, and associated outcomes.